nexgel advanced hydrogel solutions in a manufacturer of unique trans-dermal delivery system that was originally developed and fda-approved for the hospital wound care market, and is now being deployed against consumer otc, rx, medical device and cosmetic applications.
Company profile
Ticker
NXGL
Exchange
Website
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
AquaMed Technologies, Inc.
SEC CIK
Corporate docs
Subsidiaries
CG Converting and Packaging, LLC • NexGelRx, Inc. • Sport Defense LLC ...
IRS number
264042544
NXGL stock data
Latest filings (excl ownership)
8-K
Submission of Matters to a Vote of Security Holders
17 Jun 24
10-K/A
2023 FY
Annual report (amended)
13 Jun 24
8-K
NEXGEL Acquires International Beauty Brand, Silly George
20 May 24
8-K
NEXGEL Reports First Quarter 2024 Revenue of $1.27 Million, an Increase of 104% Year-Over-Year
13 May 24
10-Q
2024 Q1
Quarterly report
13 May 24
DEFR14A
Revised proxy
3 May 24
DEF 14A
Definitive proxy
29 Apr 24
10-K
2023 FY
Annual report
9 Apr 24
NT 10-K
Notice of late annual filing
2 Apr 24
8-K
Results of Operations and Financial Condition
1 Apr 24
Transcripts
NXGL
Earnings call transcript
2024 Q1
13 May 24
NXGL
Earnings call transcript
2023 Q4
1 Apr 24
NXGL
Earnings call transcript
2023 Q3
13 Nov 23
NXGL
Earnings call transcript
2023 Q2
14 Aug 23
NXGL
Earnings call transcript
2023 Q2
14 Aug 23
NXGL
Earnings call transcript
2023 Q1
15 May 23
NXGL
Earnings call transcript
2022 Q4
27 Mar 23
Latest ownership filings
4
Scott Robert Henry
5 Mar 24
4
steven mark glassman
5 Mar 24
4
Adam E Drapczuk III
5 Mar 24
4
steven mark glassman
26 Dec 23
4
John Nachum Stein
28 Sep 23
4
Scott Robert Henry
14 Sep 23
4
Scott Robert Henry
23 Aug 23
4
Miranda Jayne Toledano
21 Aug 23
4
JEROME B ZELDIS
21 Aug 23
4
John Nachum Stein
21 Aug 23
Financial summary
Quarter (USD) | Mar 24 | Dec 23 | Sep 23 | Jun 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Institutional ownership, Q2 2023
16.8% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 15 |
Opened positions | 8 |
Closed positions | 0 |
Increased positions | 3 |
Reduced positions | 2 |
13F shares | Current |
---|---|
Total value | 694.89 mm |
Total shares | 1.05 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Armistice Capital | 550.00 k | $237.60 mm |
Altium Capital Management | 225.00 k | $97.20 mm |
Clear Street | 53.61 k | $23.00 k |
Hudson Bay Capital Management | 50.00 k | $24.10 mm |
Geode Capital Management | 38.86 k | $97.54 mm |
Simon Quick Advisors | 35.72 k | $89.34 mm |
Renaissance Technologies | 26.03 k | $65.00 k |
GWM Advisors | 18.81 k | $47.05 mm |
Citadel Advisors | 14.42 k | $36.19 mm |
Jane Street | 10.69 k | $26.74 mm |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
1 Mar 24 | Scott Robert Henry | Common Stock | Buy | Acquire P | No | No | 2.11 | 23,697 | 50.00 k | 135,735 |
1 Mar 24 | Scott Robert Henry | Warrant to Purchase Common Stock Common Stock | Grant | Acquire A | No | No | 4 | 11,848 | 47.39 k | 11,848 |
1 Mar 24 | steven mark glassman | Common Stock | Buy | Acquire P | No | No | 2.11 | 11,848 | 25.00 k | 135,025 |
1 Mar 24 | steven mark glassman | Warrant to Purchase Common Stock Common Stock | Grant | Acquire A | No | No | 4 | 5,924 | 23.70 k | 5,924 |
1 Mar 24 | Adam E Drapczuk III | Common Stock | Buy | Acquire P | Yes | No | 2.11 | 47,394 | 100.00 k | 47,394 |
1 Mar 24 | Adam E Drapczuk III | Warrant to Purchase Common Stock Common Stock | Grant | Acquire A | No | No | 4 | 23,697 | 94.79 k | 23,697 |
22 Dec 23 | steven mark glassman | Common Stock | Buy | Acquire P | No | No | 2.197 | 3,885 | 8.54 k | 123,177 |
26 Sep 23 | Stein Nachum | Common Stock | Buy | Acquire P | No | No | 1.96 | 2,500 | 4.90 k | 500,019 |
News
NEXGEL Acquires All Assets Of Silly George For $400,000 In Cash, $200,000 In NEXGEL Common Stock, And A 4-Year Net Profit Earn Out; Silly George Has A Revenue Run Rate Of ~$2M
16 May 24
NexGel Q1 2024 GAAP EPS $(0.14) Beats $(0.18) Estimate, Sales $1.266M Beat $1.207M Estimate
13 May 24
Earnings Scheduled For April 1, 2024
1 Apr 24
Earnings Scheduled For March 28, 2024
28 Mar 24
NexGel's Earnings: A Preview
27 Mar 24
Press releases
NEXGEL and STADA Partner to Launch Leading European DAO Enzyme Supplement, Histasolv, in North America
11 Jun 24
NEXGEL Reports First Quarter 2024 Revenue of $1.27 Million, an Increase of 104% Year-Over-Year
13 May 24
NEXGEL to Present at the Aegis Capital Virtual Conference on May 9, 2024
6 May 24
Thinking about buying stock in Ibio, Village Farms International, MariaDB, Nexgel, or Urban Outfitters ?
27 Mar 24
NEXGEL Reschedules Fourth Quarter and Full Year 2023 Financial Results Conference Call to Monday, April 1st at 8:30 a.m. ET Due to Holiday
27 Mar 24